title: Systematic review: Monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD.
authors: Inflammatory Bowel Disease Center, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
authors: Parambir S
authors: PS
authors: Dulai
authors: Inflammatory Bowel Disease Center, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
authors: Corey A
authors: CA
authors: Siegel
authors: Icahn School of Medicine at Mount Sinai, New York, New York, USA.
authors: Jean-Frederic
authors: JF
authors: Colombel
authors: University of California San Diego, La Jolla, California, USA.
authors: William J
authors: WJ
authors: Sandborn
authors: Inserm U954, Department of Hepato-Gastroenterology, Université de Lorraine, Nancy, France.
authors: Laurent
authors: L
authors: Peyrin-Biroulet
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use; D001379:Azathioprine / Q000494:pharmacology*; D057186:Comparative Effectiveness Research; D019468:Disease Management; D004347:Drug Interactions; D004359:Drug Therapy, Combination / Q000379:methods; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000494:pharmacology*; D008727:Methotrexate / Q000494:pharmacology*; D017063:Outcome Assessment, Health Care; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha; D015122:Mercaptopurine; D001379:Azathioprine; D008727:Methotrexate
keywords: IBD